BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1686528)

  • 1. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
    Wilhelms OH; Roesch A; Schaumann W
    Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of picumast dihydrochloride on the ex vivo histamine release from leucocytes of allergic asthmatic patients.
    Zimmermann I; Roesch A; Ulmer WT
    Arzneimittelforschung; 1989 Oct; 39(10A):1351-3. PubMed ID: 2483313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
    Sekardi L; Friedberg KD
    Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma.
    Slapke J; Müller S; Boerner D
    Arzneimittelforschung; 1989 Oct; 39(10A):1368-72. PubMed ID: 2576366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of picumast dihydrochloride in comparison with placebo in asthmatic patients.
    Boerner D; Metz K; Eberhardt R
    Arzneimittelforschung; 1989 Oct; 39(10A):1363-7. PubMed ID: 2576365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of picumast dihydrochloride on antigen-induced early and late airway responses in allergic sheep.
    Abraham WM
    Arzneimittelforschung; 1989 Oct; 39(10A):1328-31. PubMed ID: 2576357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of picumast after administration of picumast dihydrochloride and antiallergic activity of the main metabolites.
    Besenfelder E; Neubert P; Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1317-20. PubMed ID: 2576355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo-controlled comparison of the efficacy and tolerability of picumast dihydrochloride and terfenadine in patients with seasonal allergic rhinitis.
    Boerner D; Metz K; Eberhardt R; Schürmann W
    Arzneimittelforschung; 1989 Oct; 39(10A):1356-9. PubMed ID: 2576363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability, safety and efficacy of picumast dihydrochloride on long-term use in patients with perennial bronchial asthma.
    Boerner D; Metz K; Eberhardt R
    Arzneimittelforschung; 1989 Oct; 39(10A):1372-4. PubMed ID: 2576367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans.
    Neugebauer G; Wittenbrink-Dix AM; Woelke-Seidl E; Kaufmann B; Ponton T; Dahmen W; Mosberg H; Nieder N; Besenfelder E
    Arzneimittelforschung; 1989 Oct; 39(10A):1336-9. PubMed ID: 2576358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind multicenter controlled clinical study comparing the efficacy of picumast dihydrochloride versus astemizole and placebo in patients with seasonal allergic rhinitis.
    Franke W; Messinger D
    Arzneimittelforschung; 1989 Oct; 39(10A):1360-3. PubMed ID: 2576364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge.
    Franke W; Bachert C; Messinger D
    Arzneimittelforschung; 1989 Oct; 39(10A):1354-6. PubMed ID: 2576362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of potential kinetic interactions of picumast dihydrochloride and theophylline in vitro and after oral administration in man.
    Wittenbrink-Dix AM; Neugebauer G; Fuhr U; Neubert P; Besenfelder E; Woelke-Seidl E; Harder S; Staib AH
    Arzneimittelforschung; 1989 Oct; 39(10A):1339-43. PubMed ID: 2576359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-allergic properties of a new coumarin compound (BM 15,100) [proceedings].
    Roesch A; Roesch E
    Br J Pharmacol; 1976 Jul; 57(3):438P. PubMed ID: 10033
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical synthesis of picumast dihydrochloride.
    Witte EC
    Arzneimittelforschung; 1989 Oct; 39(10A):1309. PubMed ID: 2576353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.
    Mita H; Shida T
    Arzneimittelforschung; 1995 Jan; 45(1):36-40. PubMed ID: 7893266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of allergic disease.
    Morris EC
    Prim Care; 1987 Sep; 14(3):605-21. PubMed ID: 2890178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of picumast after administration of 14C-picumast dihydrochloride in dogs, rats, rabbits and monkeys.
    Schaumann W; Besenfelder E; Boehm E; Neubert P; Roesch A; Sterz H
    Arzneimittelforschung; 1989 Oct; 39(10A):1321-7. PubMed ID: 2576356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.